EP1307414A2 - Utilisation et evaluation d'une photocycloaddition 2+2] dans une immobilisation d'oligonucleotides sur une matrice hydrogel tridimensionnelle - Google Patents

Utilisation et evaluation d'une photocycloaddition 2+2] dans une immobilisation d'oligonucleotides sur une matrice hydrogel tridimensionnelle

Info

Publication number
EP1307414A2
EP1307414A2 EP01957507A EP01957507A EP1307414A2 EP 1307414 A2 EP1307414 A2 EP 1307414A2 EP 01957507 A EP01957507 A EP 01957507A EP 01957507 A EP01957507 A EP 01957507A EP 1307414 A2 EP1307414 A2 EP 1307414A2
Authority
EP
European Patent Office
Prior art keywords
target
probe
polymer
microarray
reactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01957507A
Other languages
German (de)
English (en)
Inventor
Robert Elghanian
Charles K. Brush
Yanzheng Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Amersham Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Bioscience AB filed Critical Amersham Bioscience AB
Publication of EP1307414A2 publication Critical patent/EP1307414A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • C40B50/18—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support using a particular method of attachment to the solid support

Definitions

  • Chip based DNA microarrays are an integration of circuit fabrication technology and genetics.
  • DNA microarrays consist of matrices of DNA arranged on a solid surface where the DNA at each position recognizes the expression of a different target sequence.
  • Microarrays are used to identify which genes are turned on or off in a cell or tissue, and to evaluate the activity level under various conditions. This knowledge enables researchers to determine whether a cell is diseased or the effect of a drug on a cell or group of cells. These studies are critical to determine a drug's efficacy or toxicity, to identify new drug targets, and to more accurately diagnose illnesses, such as specific types of cancer.
  • Photolithography technology similar to that employed for transistor etching into silicon chips, is often used to layer chains of nucleotides, the basic units of DNA, onto silicon. Additionally, nucleotides, often referred to as "probes,” may be deposited onto solid substrates, or solid substrates coated with various polymers. Various deposition or spraying methods are used to deposit the nucleotides, including piezoelectric technology similar to that used for ink-jet printer heads and robotic methods. The probes are attached to the substrates or polymers by thermal, chemical, or light-based methods to form the microarray.
  • the genes of interest are generally put into solution in a "fluidics station” which disperses the target solution on the microarray surface. If fluorescence detection is to be used, the targets may be tagged with fluorescent labels. Nucleotide targets which are complementing, or “recognized” by, the nucleotide probes on the support or polymer then bind, or hybridize, with their corresponding probes.
  • the targets may be enzymatically tagged after hybridization to their respective probes. After rinsing to remove any unbound targets from the microarray, the presence and or concentration of specific targets is determined by spectroscopic or other methods.
  • microarrays including diagnosing mutations in HIV-1 , studying the gene defects which lead to cancer, polymorphism screening and genotyping, and isolating the genes which lead to genetic based disorders, such as multiple sclerosis.
  • a microarray is generally formed by coating a solid support with a polymer.
  • Polyacrylamides have a variety of uses and can be modified to optimize nonionic, anionic, or cationic properties for specified uses, such as a polymer coating for the solid support of a microarray.
  • Polyacrylamide hydrogels are often used as molecular sieves for the separation of nucleic acids, proteins, and other moieties, and as binding layers to adhere to the surfaces biological molecules including, but not limited to, proteins, peptides, oligonucleotides, polynucleotides, and larger nucleic acid fragments.
  • the gels currently are produced as thin sheets or slabs, typically by depositing a solution of acrylamide monomer, a crosslinker such methylene bisacrylamide, and an initiator such as N, N,
  • N', N' - tetramethylethylendiamine between two glass surfaces, such as microscope slides.
  • a spacer is used to obtain the desired thickness of polyacrylamide.
  • the acrylamide polymerization solution is a 4-5% solution (acrylamide/bisacrylamide 19/1) in water/glycerol, with a nominal amount of initiator added.
  • the solution is polymerized and crosslinked either by ultraviolet (UV) radiation (e.g., 254 nm for at least about 15 minutes, or other appropriate UV conditions, collectively termed "photopolymerization"), or by thermal initiation at elevated temperature, typically about 40° C.
  • UV radiation ultraviolet
  • photopolymerization ultraviolet radiation
  • thermal initiation at elevated temperature, typically about 40° C.
  • the top glass slide is removed from the surface to uncover the gel.
  • the pore size (or “sieving properties") of the gel is controlled by changing the amount of crosslinker and the % solids in the monomer solution.
  • the pore size also can be controlled by changing the polymerization temperature.
  • the acrylamide solution typically is imaged through a mask during the UV polymerization/crosslinking step.
  • the top glass slide is removed after polymerization, and the unpolymerized monomer is washed away with water leaving a fine feature pattern of polyacrylamide hydrogel, the crosslinked polyacrylamide hydrogel pads.
  • a polyacrylamide hydrogel can activate these specified regions for the attachment of an anti-Iigand, such as an antibody or antigen, hormone or hormone receptor, oligonucleotide, or polysaccharide, to the hydrogel (PCT International Application WO 91/07087, incorporated by reference).
  • an anti-Iigand such as an antibody or antigen, hormone or hormone receptor, oligonucleotide, or polysaccharide
  • the polyacrylamide subsequently is modified to include functional groups for the attachment of probes.
  • the probes, such as DNA, are later attached.
  • Typical procedures for attaching a biomolecule to a surface involve multiple reaction steps, often requiring chemical modification of the hydrogel to provide the chemical functionality for covalent bonding with the biomolecule.
  • the efficiency of the attachment chemistry and strength of the chemical bonds formed are critical to the fabrication and ultimate performance of the microarray.
  • the necessary functionality for probe attachment presently entails chemical modification of the hydrogel through the formation of amide, ester, or disulfide bonds after polymerization and crosslinking of the hydrogel.
  • An unresolved problem with this approach is the less than optimal stability of the attachment chemistry over time, especially during subsequent manufacturing steps, and under use conditions where the microarray is exposed to high temperatures, ionic solutions, and multiple wash steps. Such conditions promote continued depletion in the quantity of probe molecules present in the array, thus reducing its performance and useful life.
  • a further problem is the low efficiency of the method.
  • Another approach that has been employed is the polymerization of a suitable "attachment co-monomer" into the polyacrylamide matrix that is capable of bonding with the DNA oligonucleotide probe.
  • this method is limited in that the incorporation of the attachment co-monomer as a third component of the matrix, along with the acrylamide monomer and crosslinker, can give rise to problems during acrylamide polymerization. These problems include an inability to form the matrix, a loss of mechanical integrity in the matrix, and a loss of adhesion between the matrix and the solid support.
  • a more recent method has employed direct co-polymerization of an acrylamide-derivatized oligonucleotide.
  • ACRYDITE Mosaic Technologies, Boston, MA
  • Acrydite-modified oligonucleotides are mixed with acrylamide solutions and polymerized directly into the gel matrix (Rehman et al., Nucleic Acids Research, 27, 649-655 (1999). This method still relies on acrylamide as the monomer.
  • similar problems in the stability of attachment as with the above-mentioned methods, also result.
  • the prior art methods use post-modification of the matrix, or incorporation of a suitable co-monomer during the fabrication process.
  • toxic acrylamide monomer is used in manufacturing the arrays.
  • the present invention seeks to overcome some of the aforesaid disadvantages of the prior art, including the problems associated with chemical attachment of the probes to the polymer-coated support, for the purpose of forming microarrays useful in expression and single nucleotide polymorphism (SNP) analysis.
  • SNP single nucleotide polymorphism
  • the present invention provides methods of performing expression and SNP microarray analysis to determine the presence and/or concentration of a target, wherein a microarray is formed by attaching a polymer-coated support and a probe by a [2 + 2] cycloaddition reaction, wherein the reaction is between reactive sites on the polymer and probe.
  • Novel hydrogel arrays are used to detect specific target oligonucleotides, including mRNA and DNA. Expression and single nucleotide polymorphism analyses are performed.
  • the arrays are constructed from polyacrylamide based hydrogels and synthetic oligonucleotide probes that are functionalized with reactive groups. The reactive groups undergo [2 + 2] type photocycloaddition when exposed to ultraviolet light. This cycloaddition results in the probes being covalently attached to the hydrogel.
  • Figure 1 shows a plot of the fluorescence intensities of different yeast transcripts detected on an expression microarray when each was spiked into human placental poly (A)+ mRNA at a mass ratio of 1 in 300,000 (about one copy per cell).
  • Figure 2 is a comparison of signaling performance across three attachment chemistries: methacrylamide, cinnamide, and cinnamide with a linker.
  • the current invention relates to a novel method of performing gene analyses, including expression and SNP, using hydrogel microarrays in which acrylamide is polymerized in a controlled fashion to obtain a "prepolymer", which is then photochemically crosslinked and attached using [2 + 2] photocycloaddition chemistry to oligonucleotide probes, including DNA.
  • the prepolymer and probes contain reactive sites, which are inherent or added by chemical means, that form covalent bonds upon irradiation with light.
  • microarrays are a collection of probe binding sites at known physical locations bound on a surface. By positioning tiny specks of probe molecules at known surface locations and then exposing a collection of target molecules to the probes, selective binding occurs between specific probes and targets. For example, because adenine only binds to thymine, a thymine probe will selectively bind to an adenine target.
  • probe/target binding occurs, unbound targets are washed away and the microarray is analyzed to determine which targets have bound at what probe locations on the microarray. If an internal standard is included with the targets, and probes are provided for the standard on the microarray, quantitative determinations may also be made. Because a plethora of different probes can be deposited on a single microarray, numerous types of binding analyses can be simultaneously performed. Express ⁇ on/Targets
  • Expression microarrays are used to detect the presence of nucleic acids or polynucleotides generated, or expressed, by genes. These nucleic acids, or “targets,” are preferably messenger RNA, RNA, DNA, amplified RNA, amplified DNA or modifications thereof, and more preferably mRNA, DNA, or RNA. They may be taken from any biological source, including healthy or diseased tissue, tissues that have been exposed to drugs, and pathogens. Because expression microarrays are often used to determine if a tissue is expressing different biomolecules than normal due to disease or drug treatment, the targets of interest are often nucleotides produced by these tissues.
  • the targets of interest are labeled with dyes or other compounds that fluoresce when irradiated with , light of a known wavelength.
  • the labels are attached to the targets by standard chemical/enzymatic methods known to one of skill in the art, as found in Lockhart, et al., Nature Biotechnology, 14: 1675-80, (1996), for example.
  • the fluorescent emission from the labeled nucleic acids allows their detection by spectroscopic methods. By scanning the expression microarray with light at the excitation wavelength or wavelengths of the dyes used, the labeled nucleic acids may be detected. By placing different dyes on different targets, multiple determinations may be made from a single microarray.
  • the literature contains examples of many fluorescent dyes suitable for labeling the targets.
  • Preferred labels include those sold under the tradename ALEXA FLUOR. These labels are dyes with trade secret compositions which may be purchased from Molecular Probes, Inc. (849 Pitchford Avenue, Eugene, OR 97402-9165 USA).
  • Other preferred labels include the cyanine dyes prepared with succinimidyl ester reactive groups, such as Cy-3, Cy-5, Cy-5.5. The number immediately after the "Cy" indicates the number of bridge carbons. The number following the decimal point indicated a unique dye structure, which is determined by the substituents on the structure. Cy-3, Cy-5, and Cy-5.5 are available from Amersham Pharmacia Biotech (Piscataway, N.J., USA). Cy-3 is most preferred.
  • expression microarrays may be used to simultaneously make a quantitative determination of the detected targets. This is possible by incorporating "probe standards" into the microarray which selectively bind to specific "target standards,” but do not interfere with analyte probe/target binding.
  • Preferred target standards are yeast mRNA and bacterial mRNA, or combinations thereof. Yeast mRNA is most preferred.
  • the target standards are also fluorescently labeled to allow detection and quantitation.
  • the fluorescence intensity of the labeled targets is compared with that of the labeled target standards to determine the ratio of target to target standard.
  • a quantitative target determination is made.
  • probe and probe standards are applied to the hydrogel in about equal amounts.
  • An expression microarray is performed by first preparing an aqueous target solution containing the targets of interest in an aqueous buffer solution.
  • the target solution contains a buffer suitable to maintain pH from about 6 to 9, more preferably the solution contains a phosphate and sodium chloride buffer, most preferably the solution contains about 700 mmol. of sodium chloride and 100 mmol. of a phosphate.
  • Useful buffers may be made from purchased reagents or bought pre-prepared from SIGMA (St. Louis, MO), among others. If a quantitative determination is desired, a known concentration of target standards is also added to the aqueous target solution.
  • the microarray is developed. Development is preferably conducted for the minimum amount of time required to obtain useful results. This time may range from minutes to hours, depending on conditions and may be performed in an enclosed miniaturized chamber. Preferably, development continues for 1 minute to 42 hours, more preferably for 10 minutes to 24 hours and most preferably for about 16 hours. Development is preferably conducted from 25 to 50° C, more preferably from 30 to 45° C, and most preferably at about 37° C.
  • the microarray is cooled to about room temperature and washed with an appropriate aqueous wash solution to remove unbound targets.
  • the solution contains a phosphate buffer, more preferably the solution contains a phosphate and sodium chloride buffer, most preferably the solution contains about 300 mmol. of sodium chloride and 100 mmol. of a phosphate.
  • Useful buffers may be made from purchased reagents or bought pre-prepared from SIGMA (St. Louis, MO), among others. Although not required, a buffer similar to that used for the aqueous target solution may be used, albeit with a lower sodium chloride concentration.
  • the microarray After drying at about room temperature, the microarray is scanned in an appropriate spectrophotometer to collect fluorescence position and optionally, intensity data. If Cy-3 is used as the fluorescent label for the targets, scanning is conducted at 532 nanometers. Other scanning wavelengths are possible, as dictated by the labels used.
  • a preferable scanner is an AXON SERIES A, available from AXON INSTRUMENTS, Union City, California, or equivalent. For quantitative analysis, the scanner, or optional processor, computes the intensity ratio of target to target standard fluorescence.
  • single nucleotide polymorphism (SNP) microarrays are similar to expression microarrays, including their use of oligonucleotide probes and nucleic acid targets.
  • SNP single nucleotide polymorphism
  • the targets are labeled prior to their dispersion on the microarray.
  • the aqueous target solution in addition to buffers, contains non- labeled targets, an active enzyme, a fluorescently labeled carrier, and optionally, target standards.
  • SNP microarrays While expression microarrays rely on selective probe/target binding to generate a fluorescent pattern on the array, SNP microarrays rely on enzyme selective single base extension (SBE) of a selected probe/target complex. During development of the SNP microarray, the targets bind to their respective probes to form a complex, generally having a double-helix structure. If an appropriate complex is recognized by the active enzyme, it transfers the label by a SBE reaction from the carrier to the complex. Thus, fluorescent probe/target sites are selectively created.
  • SBE enzyme selective single base extension
  • the SNP microarray may then be washed and scanned similarly to an expression array to confirm the presence of a specific target, and optional quantitation, if probe and target standards are used.
  • Preferable active enzymes include any enzyme capable of transferring a label to a probe/target complex by SBE. More preferable enzymes include labeled thermosequanase and other DNA polymerases, or combinations thereof. Most preferred is thermosequanase, available from Amersham Pharmacia Biotech (Piscataway, N.J., USA).
  • Preferable fluorescent label carriers include any carrier which can provide a transferable label to an active enzyme for transfer to a probe/target complex. More preferable fluorescent label carriers include labeled di- deoxynucleotide triphosphate and other labeled synthetic di-deoxy cyclic or acyclic nucleotides, or combinations thereof. Most preferred is labeled di- deoxynucleotide triphosphate.
  • SNP development entails cycling the temperature preferably between 20 and 80° C, more preferably between 30 and 70° C, and most preferably between 40 and 60° C for preferably 20 to 70 heating/cooling cycles, more preferably for 30 to 60 heating/cooling cycles, and most preferably for 40 to 50 heating/cooling cycles.
  • the wash is also conducted with a similar wash solution as used to wash an expression microarray, but the aqueous solution is preferably between 30 and 80° C, more preferably between 40 and 70° C, and most preferably between 50 and 60° C.
  • the polymer or polyacrylamide reactive prepolymer is coated onto a solid support.
  • the "solid support” is any solid support that can serve as a support for the polyacrylamide prepolymer, including film, glass, silica, modified silicon, ceramic, plastic, or polymers such as (poly)tetrafluoroethylene, or (poly)vinylidenedifluoride.
  • the solid support is a material selected from the group consisting of nylon, polystyrene, glass, latex, polypropylene, and activated cellulose.
  • the solid support is glass.
  • the solid support can be any shape or size, and can exist as a separate entity or as an integral part of any apparatus, such as beads, cuvettes, plates, and vessels. If required, the support may be treated to provide adherence of polyacrylamide to the glass, such as with ⁇ -methacryl-oxypropyl-trimethoxysilane ("Bind Silane," Pharmacia). In particular, covalent linkage of polyacrylamide hydrogel to the solid support can be done as described in European Patent Application 0 226470, incorporated by reference.
  • the solid support may optionally contain electronic circuitry used in the detection of bit molecules, or microfluidics used in the transport of micromolecules.
  • the solid support is coated with an acrylamide prepolymer, which may be coated and imaged using standard commercial equipment.
  • the prepolymer is non-toxic, easily handled, can be manufactured in highly consistent batches, and has good viscosity characteristics for coating surfaces during microarray manufacture.
  • the synthesis and use of prepolymers for gel pad formation is described, for example, in U.S. Application Serial Number 60/109,821 , filed November 25, 1998.
  • the prepolymer can be functionalized by the addition of one or more reactive sites.
  • a detailed description of polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers is given in U.S. Patent Application Serial Number 09/344,217, filed June 25, 1999, entitled
  • Conversion of the prepolymer into a three-dimensional polyacrylamide hydrogel array may entail additional steps, including developing the pattern in the array and removing any uncrosslinked polymer. Pattern development can be accomplished by exposing the reactive prepolymer through a photomask. Uncrosslinked polymer may also be removed by aqueous solution.
  • the polymer is a polymer or copolymer made of at least two co-monomers that form a three-dimensional hydrogel, wherein at least one of the co-monomers can react by [2 + 2] photocycloaddition.
  • the polymer is a polymer or copolymer that forms a three- dimensional hydrogel which is then chemically modified to contain a reactive site that undergoes [2 + 2] photocycloaddition.
  • the polymer is an acrylamide reactive prepolymer made by polymerizing acrylamide with a compound including- dimethyl maleimide (DMI), a six carbon linker, and a polymerizable group, such as acrylate, to give a low molecular weight polymer.
  • DMI dimethyl maleimide
  • the polymerizable group attaches to the acrylamide to form the hydrogel and the dimethyl maleimide attaches the resultant hydrogel to the solid support, and optionally to the probe if crosslinking and probe attachment are performed concurrently.
  • the DMI dimethyl maleimide
  • Probes are attached to the polymer by [2 + 2] photocycloaddition between reactive sites on the polymer or reactive prepolymer and the probe.
  • Preferable probes are nucleic acids or fragments thereof containing less than about 5000 nucleotides, especially less than about 1000 nucleotides.
  • a probe is an oligonucleotide, such as DNA or modifications thereof. Probes may be tissue or pathogen specific
  • probes or biomolecules inherently contain reactive sites or have been functionalized with a reactive site by chemical means.
  • Preferred probes requiring no further modification include certain nucleic acid species that incorporate pyrimidines such as thymine.
  • Other preferred probes are modified to contain thymine or polythymine, or proteins incorporating thiols.
  • Modified DNA oligonucleotides or polynucleotides are employed as probes that include a reactive site capable of undergoing [2 + 2] photocycloaddition. Additionally, the hydrogel polymer supports include reactive sites that are capable of undergoing [2 + 2] photocycloaddition. When irradiated with ultraviolet light at an appropriate wavelength, the probes are then attached to the hydrogel by [2 + 2] cycloaddition between the reactive sites.
  • the reactive site is introduced into the nucleic acid species by synthesizing or purchasing DNA functionalized with amine which is then reacted with the molecule having the desired reactive site to obtain DNA having the reactive site. Maleimide or acrylate functionalized DNA are examples.
  • Preferable reactive sites include, dimethyl maleimide, maleimide, acrylate, acrylamide, vinyl, cinnamyl groups from cinnamic acid, cinnamate, chalcones, coumarin, citraconimide, electron deficient alkenes such as cyano alkene, nitro alkene, sulfonyl alkene, carbonyl alkene, arylnitro alkene, pyrimidine bases, thymine, and polythymine.
  • acrylate thymine
  • dimethyl maleimide DMI
  • Reactive sites may be attached to the probe either directly or with an appropriate intermediate.
  • a preferred intermediate is phosphoramidite.
  • phosphoramidite is functionalized with a cinnamide and then attached to the oligonucleotide (5' position for DNA) to form a probe ready for [2 + 2] photocycloaddition.
  • Other preferred reactive sites are as described in Guillet, "Polymer Photophysics and Photochemistry", Chapter 12 (Cambridge University Press: Cambridge, London).
  • maleimide/N-hydroxysuccinimide (NHS) ester derivatives include 3-maleimidoproprionic acid hydroxysuccinimide ester; 3-maIeimidobenzoic acid N-hydroxy succinimide; N-succinimidyl 4-malimidobutyrate; N-succinimidyl 6-maleimidocaproate; N-succinimidyl 8-maleimidocaprylate; N-succinimidyl 11-maIeimidoundecaoate. These esters can be obtained from a variety of commercial vendors, such as ALDRICH (Milwaukee, Wl).
  • Reactive sites can yield homologous linking, where a probe reactive site cyclizes with a hydrogel reactive site having the same chemical structure, or for heterologous linking, where a probe reactive site cyclizes with a hydrogel reactive site having a different chemical structure.
  • Preferred homologous linking occurs between DMI reactive sites on the probe and hydrogel, while preferred heterologous linking occurs between acrylate reactive sites on the probe and DMI reactive sites on the hydrogel.
  • cDNA is a preferred probe for either type of cyclization.
  • Reactive sites can be attached to probes through linkers.
  • An example is the attachment of maleimide to a synthetic oligonucleotide bearing a primary amine at the 5' end.
  • 3-Maleimidopropionic acid hydroxysuccinimide ester reacts with the primary amine to yield an oligonucleotide bearing the maleimide group, which can then be coupled to dimethyl maleimide in a hydrogel by a [2 + 2] photocycloaddition.
  • a similar reaction can be done on the free E-amino group of lysine in a protein to provide a maleimide group for 2+2 coupling of the protein to the hydrogel.
  • Other attachment methods are described in Hermanson, Bioconjugation Chemistry.
  • probes include a linker region.
  • the linker region is a portion of the molecule which physically separates the reactive site, which undergoes [2 + 2] photocycloaddition, from the remainder of the molecule.
  • a linker region may also separate a reactive site from the polymer support.
  • linker regions are known and have been described in the art, and in some cases, may be commercially available, such as biotin (long arm) maleimide, available from GLEN RESEARCH, Sterling, VA, for example. Any linker region can be employed, so long as the linker region does not negate the desirable properties of the biomolecule, including the ability of the nucleic acid species to function as a probe.
  • Preferred linker regions are organic chains of about 6 to 100 atoms long, such as (CH 2 ) 6 NH, (CH 2 CH 2 O) CH 2 CH 2 NH, etc. Additionally, linkers may be linked to each other, or to different types of linkers, to extend their chain length.
  • photocycloaddition is a light-induced reaction between two reactive groups, at least one of which is electronically excited.
  • Photocycloaddition includes cyclodimerization and preferably includes [2 +2] photocycloaddition.
  • photocycloaddition is of the "[2 + 2]” variety, wherein two carbon-carbon or carbon-heteroatom single bonds are formed in a single step.
  • the [2 + 2] cycloaddition involves addition of a 2 ⁇ -component of a double bond to the 2 ⁇ -component of a second double bond.
  • the reaction may proceed by way of a 2 ⁇ -component of triple bonds. Under the rules of orbital symmetry, such additions are thermally forbidden, but photochemically allowed.
  • Such reactions typically proceed with a high degree of stereospecificity and regiospecificity.
  • Photochemical [2 + 2] cycloaddition of the probe to the hydrogel is obtained as follows. A reactive site is incorporated into the probe. A second reactive site is incorporated into the polyacrylamide hydrogel following or as part of its polymerization, and prior to crosslinking.
  • a photosensitiser may be added to the hydrogel or reactive prepolymer to increase the efficiency of the photocycloaddition reaction.
  • Preferred photosensitisers include water soluble quinones and xanthones, including anthroquinone, sulfonic acid quinone, benzoin ethers, acetophenones, benzoyl oximes, acylphosphines, benzophenones, and TEMED (N,N,N',N'- tetramethylethylendiamine).
  • Anthroquinone-2-sulfonic acid is most preferred and is available from ALDRICH, Milwaukee, Wl.
  • Preferred [2 + 2] cycloadditions include those between two carbon-carbon double bonds to form cyclobutanes and those between alkenes and carbonyl groups to form oxetanes.
  • Photocycloadditions between 2 alkenes to form cyclobutanes can be carried out by photo-sensitization with mercury or directly with short wavelength light, as described in Yamazaki et al., J. Am. Chem. Soc. 91, 520 (1969). The reaction works particularly well with electron-deficient double bonds because electron-poor olefins are less likely to undergo undesirable side reactions.
  • Hydrogel microarrays are formed by applying the polyacrylamide reactive prepolymer to a solid support and then attaching the desired probes by [2 + 2] photocycloaddition to give a three- dimensional hydrogel with probes embedded in an array pattern.
  • the reactive prepolymer is also crosslinked to form a hydrogel.
  • crosslinking occurs either prior to or simultaneously with probe attachment.
  • Crosslinking of the prepolymer and probe attachment is preferably done with ultraviolet irradiation. Prior to irradiation with ultraviolet light to photocyclize the reactive sites on the probes with those on the reactive prepolymer or hydrogel, the probes are dispersed at known array locations on the reactive prepolymer or crosslinked hydrogel. Piezoelectric or other methods may be used to disperse the solution containing the probes and optional probe standards.
  • This example demonstrates the sensitivity of a microarray of the present invention.
  • Three probes on the microarray represent each gene.
  • probes directed against eight different yeast mRNAs were included on the chip to determine sensitivity.
  • One ⁇ g of human placental poly(A) + RNA was spiked with 17 pg of yeast poly(A) + RNA in an aqueous buffer solution containing 700 mmol. NaCI and 100 mmol. phosphate to form an aqueous target solution.
  • the aqueous solution was the added to the array and incubated at 37° C for about 16 hours.
  • the microarray was then washed with an aqueous buffer containing 300 mmol. NaCI and 100 mmol. phosphate to remove any unbound RNA and allowed to dry.
  • the developed and washed microarray was then transferred to an Axon Series A scanner.
  • Figure. 1 shows a plot of the fluorescence intensity of different yeast transcripts detected when each was spiked into human placental poly (A)+ RNA at a mass ratio of 1 in 300,000 (equivalent to about one copy per cell). Seven out of eight probes (each probe corresponding to a different yeast transcript) were significantly over the background cutoff fluorescence signal. Cutoff is defined as the mean signal of the blank pads plus three standard deviations which gives a 99.7% likelihood of having a real signal. The sensitivity of the assay on this platform has thus been shown to be down to 17 pg of starting poly (A)+ RNA.
  • the cRNA targets for gene expression monitoring on the expression microarray chip are either total RNA or poly(A) mRNA that were amplified and biotin-labeled as described in Lockhart, et al., Nature Biotechnology. 14: 1675-80, (1996).
  • poly (A) RNA were converted into double-strand cDNA using T7-d (T)24 oligo primer and SUPERSCRIPT choice system (INVITROGEN, Carlsbad, CA).
  • T7 transcriptase MEGA T7 kit
  • the biotin labeled cRNA was purified by QIAGEN RNEASY column from Qiagen, Inc., Valencia, CA and quantitated by measuring absorbance at 260 nm corresponding to 40 ⁇ g/mL.
  • the expression chips were then hybridized using biotin labeled cRNA targets in the concentration of 0.08 ⁇ g/ ⁇ l of buffer containing MOTOROLA HYBRIDIZATION buffer (MOTOROLA LIFE SCIENCES, Northbrook, IL) at 37° C for 18 hrs.
  • MOTOROLA LIFE SCIENCES Northbrook, IL
  • the array was then washed with an aqueous buffer containing TRIZMA (SIGMA, St. Louis, MO), sodium chloride and TWEEN-20.
  • TRIZMA SIGMA, St. Louis, MO
  • the gene expression assay was performed using biotin- labeled cRNA generated from human placenta, brain and heart mRNA. Ten 30 mer human gene expression probes which give different expression levels and ten yeast probes were built on the chip. The targets were prepared using human mRNA with different ratios of yeast mRNA added for monitoring the sensitivity and dynamic range of the platform performances. The microarray could detect gene expression at three copy per cell sensitivity.

Abstract

L'invention concerne des groupes fonctionnels photofixables [2+2] incorporés dans des hydrogels à base de polyacrylamide et des sondes oligonucléotidiques synthétiques. Les sondes sont fixées photochimiquement par liaison covalente sur une surface tridimensionnelle d'un hydrogel. Les microréseaux d'hydrogel obtenus sont destinés à détecter des oligonucléotides spécifiques cibles, notamment l'ARNm et l'ADN, adaptés à des analyses de microréseaux de type polymorphisme de nucléotide simple et à des analyses d'expression.
EP01957507A 2000-08-09 2001-08-09 Utilisation et evaluation d'une photocycloaddition 2+2] dans une immobilisation d'oligonucleotides sur une matrice hydrogel tridimensionnelle Withdrawn EP1307414A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22407000P 2000-08-09 2000-08-09
US224070P 2000-08-09
US23230500P 2000-09-12 2000-09-12
US232305P 2000-09-12
PCT/US2001/024894 WO2002012566A2 (fr) 2000-08-09 2001-08-09 Utilisation et evaluation d'une photocycloaddition [2+2] dans une immobilisation d'oligonucleotides sur une matrice hydrogel tridimensionnelle

Publications (1)

Publication Number Publication Date
EP1307414A2 true EP1307414A2 (fr) 2003-05-07

Family

ID=26918399

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01957507A Withdrawn EP1307414A2 (fr) 2000-08-09 2001-08-09 Utilisation et evaluation d'une photocycloaddition 2+2] dans une immobilisation d'oligonucleotides sur une matrice hydrogel tridimensionnelle

Country Status (3)

Country Link
EP (1) EP1307414A2 (fr)
AU (1) AU2001279244A1 (fr)
WO (1) WO2002012566A2 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921638B2 (en) 1999-06-25 2005-07-26 Amersham Biosciences Ab Hydrogel-based microarray signal amplification methods and devices therefor
US6664061B2 (en) * 1999-06-25 2003-12-16 Amersham Biosciences Ab Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
EP2789383B1 (fr) 2004-01-07 2023-05-03 Illumina Cambridge Limited Réseaux moléculaires
GB0514936D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Preparation of templates for nucleic acid sequencing
US9012022B2 (en) 2012-06-08 2015-04-21 Illumina, Inc. Polymer coatings
AU2013380645B2 (en) 2013-03-08 2018-03-15 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
EP2964624B1 (fr) 2013-03-08 2017-01-04 Illumina Cambridge Limited Composés de rhodamine et leur utilisation comme marqueurs fluorescents
AU2014284584B2 (en) 2013-07-01 2019-08-01 Illumina, Inc. Catalyst-free surface functionalization and polymer grafting
EP3084523B1 (fr) 2013-12-19 2019-07-03 Illumina, Inc. Substrats comprenant des surfaces à nano-motifs et procédés de préparation associés
US10537889B2 (en) 2013-12-31 2020-01-21 Illumina, Inc. Addressable flow cell using patterned electrodes
GB201408077D0 (en) 2014-05-07 2014-06-18 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
GB201508858D0 (en) 2015-05-22 2015-07-01 Illumina Cambridge Ltd Polymethine compounds with long stokes shifts and their use as fluorescent labels
ES2945607T3 (es) 2015-07-17 2023-07-04 Illumina Inc Láminas de polímero para aplicaciones de secuenciación
GB201516987D0 (en) 2015-09-25 2015-11-11 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
US10385214B2 (en) 2016-09-30 2019-08-20 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
JP2020504074A (ja) 2016-12-22 2020-02-06 イルミナ ケンブリッジ リミテッド クマリン化合物および蛍光標識としてのそれらの使用
GB201711219D0 (en) 2017-07-12 2017-08-23 Illumina Cambridge Ltd Short pendant arm linkers for nucleotides in sequencing applications
GB201716931D0 (en) 2017-10-16 2017-11-29 Illumina Cambridge Ltd New fluorescent compounds and their use as biomarkers
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
NL2023327B1 (en) 2019-03-01 2020-09-17 Illumina Inc Multiplexed fluorescent detection of analytes
WO2020178231A1 (fr) 2019-03-01 2020-09-10 Illumina, Inc. Détection fluorescente multiplexée d'analytes
EP3931190A1 (fr) 2019-03-01 2022-01-05 Illumina Cambridge Limited Composés de coumarine substitués par une amine tertiaire et leurs utilisations en tant que marqueurs fluorescents
WO2020178162A1 (fr) 2019-03-01 2020-09-10 Illumina Cambridge Limited Composés coumarines substitués par une amine éxocyclique et leurs utilisations en tant que marqueurs fluorescents
US11421271B2 (en) 2019-03-28 2022-08-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing using photoswitchable labels
CN114829369A (zh) 2019-11-27 2022-07-29 伊鲁米纳剑桥有限公司 含环辛四烯的染料和组合物
JP2023531009A (ja) 2020-06-22 2023-07-20 イルミナ ケンブリッジ リミテッド ３’アセタールブロッキング基を有するヌクレオシド及びヌクレオチド
WO2022023353A1 (fr) 2020-07-28 2022-02-03 Illumina Cambridge Limited Colorants à base de coumarine substitués et leurs utilisations en tant que marqueurs fluorescents
US20220195516A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Methods, systems and compositions for nucleic acid sequencing
US20220195196A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Alkylpyridinium coumarin dyes and uses in sequencing applications
US20220195517A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Long stokes shift chromenoquinoline dyes and uses in sequencing applications
US20220195518A1 (en) 2020-12-22 2022-06-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing
CA3215598A1 (fr) 2021-05-05 2022-11-10 Michael Callingham Colorants fluorescents contenant des heterocycles fusionnes contenant du bis-bore et leurs utilisations dans le sequencage
KR20240009435A (ko) 2021-05-20 2024-01-22 일루미나, 인코포레이티드 합성에 의한 시퀀싱을 위한 조성물 및 방법
CN117813390A (zh) 2021-12-16 2024-04-02 因美纳有限公司 用于表面结合的多核苷酸的金属定向裂解的方法
CN117813399A (zh) 2021-12-20 2024-04-02 因美纳有限公司 用于化学裂解表面结合的多核苷酸的高碘酸盐组合物和方法
WO2023122491A1 (fr) 2021-12-20 2023-06-29 Illumina Cambridge Limited Compositions de periodate et méthodes de clivage chimique de polynucléotides liés à la surface
AU2023246676A1 (en) 2022-03-28 2024-01-18 Illumina Inc. Labeled avidin and methods for sequencing
WO2023186819A1 (fr) 2022-03-29 2023-10-05 Illumina Cambridge Limited Colorants de chroménoquinoléine et leurs utilisations dans le séquencage
AU2023246691A1 (en) 2022-03-30 2024-01-18 Illumina, Inc. Methods for chemical cleavage of surface-bound polynucleotides
US20230332197A1 (en) 2022-03-31 2023-10-19 Illumina Singapore Pte. Ltd. Nucleosides and nucleotides with 3' vinyl blocking group
US20230357845A1 (en) 2022-03-31 2023-11-09 Illumina, Inc. Compositions and methods for improving sequencing signals
WO2023232829A1 (fr) 2022-05-31 2023-12-07 Illumina, Inc Compositions et procédés de séquençage d'acides nucléiques
WO2024003087A1 (fr) 2022-06-28 2024-01-04 Illumina, Inc. Colorants fluorescents contenant un hétérocycle de bore bis tétracyclique fusionné et leurs utilisations dans le séquençage
WO2024039516A1 (fr) 2022-08-19 2024-02-22 Illumina, Inc. Détection de la troisième paire de bases de l'adn spécifique de site
US20240140939A1 (en) 2022-09-30 2024-05-02 Illumina Cambridge Limited Compositions and methods for reducing photo damage during sequencing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919915A1 (de) * 1989-06-19 1990-12-20 Boehringer Mannheim Gmbh Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
US5582955A (en) * 1994-06-23 1996-12-10 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Chemical functionalization of surfaces
EP2319855B1 (fr) * 1997-01-08 2016-04-06 Sigma-Aldrich Co. LLC Bio-conjugaison de macromolécules
CN1334871A (zh) * 1998-12-10 2002-02-06 宝酒造株式会社 将dna固定在载体上的方法
US6372813B1 (en) * 1999-06-25 2002-04-16 Motorola Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays
WO2001084234A1 (fr) * 2000-05-01 2001-11-08 Proligo Llc Procede d'immobilisation d'oligonucleotides au moyen du procede de bioconjugaison de cycloaddition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0212566A3 *

Also Published As

Publication number Publication date
WO2002012566A2 (fr) 2002-02-14
AU2001279244A1 (en) 2002-02-18
WO2002012566A3 (fr) 2003-01-09

Similar Documents

Publication Publication Date Title
US6664061B2 (en) Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
EP1307414A2 (fr) Utilisation et evaluation d'une photocycloaddition 2+2] dans une immobilisation d'oligonucleotides sur une matrice hydrogel tridimensionnelle
EP1190254B1 (fr) Procedes et compositions permettant de fixer des biomolecules a des supports solides, a des hydrogels et a des matrices d'hydrogels
EP1147222B1 (fr) Reseau de sondes replicables
US7354706B2 (en) Use of photopolymerization for amplification and detection of a molecular recognition event
US20030082604A1 (en) High density arrays
JP3883539B2 (ja) エポキシ基を有する放射状ポリエチレングリコール誘導体を用いたハイドロゲルバイオチップの製造方法
US20070004027A1 (en) Method for manufacturing a biosensor element
JP2001108683A (ja) Ｄｎａ断片固定固相担体、ｄｎａ断片の固定方法および核酸断片の検出方法
JP2002176977A (ja) プローブ分子が固定された検出具の処理方法及び水性処理液
WO1999051770A1 (fr) Nouveau procede de preparation de puces micromatricielles composees et puces micromatricielles composees ainsi obtenues
US6921638B2 (en) Hydrogel-based microarray signal amplification methods and devices therefor
JP3448654B2 (ja) バイオチップ、バイオチップアレイ、及びそれらを用いたスクリーニング方法
JP4526388B2 (ja) バイオチップの製造方法
JP3342695B2 (ja) 反応性固相担体及びｄｎａ断片検出用具
JP3568197B2 (ja) 反応性固相担体及びｄｎａ断片検出用具
KR100498288B1 (ko) 핵산 마이크로어레이 및 이의 제조방법
WO2006031248A2 (fr) Utilisation de la photopolymerisation pour amplifier et detecter un evenement de reconnaissance moleculaire
JP2002365295A (ja) 生体活性物質分析素子製造用の表面活性シートロール
JP2001178459A (ja) 固相担体表面へのｄｎａ断片の固定方法及びｄｎａチップ
CN116446055A (zh) 一种具有高密度反应位点的基底的制备方法及应用
JP2003194815A (ja) 反応性固相担体及びｄｎａ断片検出用具
JP2002365292A (ja) 反応性固相担体及びｄｎａ断片検出用具
JP2002365291A (ja) 反応性核酸断片及び相補性ｄｎａ断片検出用具の製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030303

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RTI1 Title (correction)

Free format text: THE USE AND EVALUATION OF A (2+2) PHOTOCYCLOADDITION IN IMMOBILIZATION OF OLIGONUCLEOTIDES ON A THREE-DIMENSIONAL HYDROGE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GE HEALTHCARE BIO-SCIENCES AB

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301

RTI1 Title (correction)

Free format text: THE USE AND EVALUATION OF A ??2+2 PHOTOCYCLOADDITION IN IMMOBILIZATION OF OLIGONUCLEOTIDES ON A THREE-DIMENSIONAL HYDROGEL MATRIX